REFERENCES
- Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10:133–140.
- Mantagos IS, Vanderveen DK, Smith LE. Emerging treatments for retinopathy of prematurity. Semin Ophthalmol. 2009;24:82–86.
- Kristiansen G, Sammar M, Altevogt P. Tumour biological aspects of CD24, a mucin-like adhesion molecule. J Mol Histol. 2004;35:255–262.
- Sagiv E, Starr A, Rozovski U et al. Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA. Cancer Res. 2008;68:2803–2812.
- Sagiv E, Memeo L, Karin A et al. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis. Gastroenterology. 2006;131:630–639.
- Sagiv E, Kazanov D, Arber N. CD24 plays an important role in the carcinogenesis process of the pancreas. Biomed Pharmacother. 2006;60:280–284.
- Connor KM, Krah NM, Dennison RJ et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc. 2009;4:1565–1573.
- D’mato R, Weselowsk E, Smith LEH. Microscopic visualization of the retina by angiography with high molecular weight fluorescein labeled dextrans in the mouse. Microvas Res. 1993;46:135–142.
- Rabinowitz R, Katz G, Rosner M, Pri-Chen S, Spierer A. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol. 2008;246:843–848.
- Stahl A, Connor KM, Sapieha P et al. Computer-aided quantification of retinal neovascularization. Angiogenesis. 2009;12:297–301.
- Higgins RD, Yu K, Sanders RJ, Nandgaonkar BN, Rotschild T, Rifkin DB. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res. 1999;18:20–27.
- Aigner S, Ruppert M, Hubbe M et al. Heat stable antigen (mouse CD24) supports myeloid cell binding to endothelial and platelet P-selectin. Int Immunol. 1995;7: 1557–1565.
- Sammar M, Aigner S, Hubbe M et al. Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol. 1994;6:1027–1036.
- Aigner S, Sthoeger ZM, Fogel M et al. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood. 1997;89:3385–3395.
- Su D, Deng H, Zhao X et al. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA. Cytotherapy. 2009;11:642–652.